These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1433799)

  • 41. Use of plasma exchange in methotrexate removal in a patient with osteosarcoma and acute renal insufficiency.
    Cecyn KZ; Lee J; Oguro T; Petrilli AS; Bordin JO
    Am J Hematol; 2003 Mar; 72(3):209-11. PubMed ID: 12605394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High dose methotrexate in adult patients with osteosarcoma: clinical and pharmacokinetic results.
    Comandone A; Passera R; Boglione A; Tagini V; Ferrari S; Cattel L
    Acta Oncol; 2005; 44(4):406-11. PubMed ID: 16120550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. No correlation between methotrexate serum level and histologic response in the pre-operative treatment of extremity osteosarcoma.
    Bacci G; Loro L; Longhi A; Bertoni F; Bacchini P; Versari M; Picci P; Serra M
    Anticancer Drugs; 2006 Apr; 17(4):411-5. PubMed ID: 16549998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Delayed methotrexate clearance in osteosarcoma patients treated with multiagent regimens of neoadjuvant chemotherapy.
    Bacci G; Ferrari S; Longhi A; Forni C; Loro L; Beghelli C; Tremosini M; Versari M
    Oncol Rep; 2003; 10(4):851-7. PubMed ID: 12792734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preoperative administration of high-dose methotrexate for osteosarcoma.
    Chan KW; Knowling MA; Duncan CP; Morton KS
    Can J Surg; 1984 May; 27(3):305-7, 309. PubMed ID: 6586272
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.
    Patiño-García A; Zalacaín M; Marrodán L; San-Julián M; Sierrasesúmaga L
    J Pediatr; 2009 May; 154(5):688-93. PubMed ID: 19159907
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methotrexate megadosage followed by folate rescue. I. A study in clearance patterns.
    Salasoo S; Irving MG; Lam-Po0Tang R; O'Gorman-Hughes D; Freedman A
    Med J Aust; 1976 May; 1(21):777-9. PubMed ID: 1085404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Total femur replacement.
    Marcove RC; Lewis MM; Rosen G; Huvos AG
    Compr Ther; 1977 Feb; 3(2):13-9. PubMed ID: 300049
    [No Abstract]   [Full Text] [Related]  

  • 49. [Evaluation of severe side effects of high-dose methotrexate in osteosarcoma].
    Umeda T; Takada N; Hodaka E; Endoh F; Ishii T
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):285-94. PubMed ID: 6582805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy?
    Bacci G; Picci P; Gherlinzoni F; Van Horn JR; Orlandi M; Normand AR; Manfrini M; Pignatti G; Campanacci M
    Chemioterapia; 1986 Apr; 5(2):140-3. PubMed ID: 3458546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Delayed renal excretion of methotrexate after a severe anaphylactic reaction to methotrexate in a child with osteosarcoma.
    Ozguven AA; Uysal K; Gunes D; Koroglu T; Gurcu O; Olgun N
    J Pediatr Hematol Oncol; 2009 Apr; 31(4):289-91. PubMed ID: 19346884
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Individualization of the dosage of high-dose methotrexate by assaying plasma concentration. Therapeutic value in osteogenic sarcoma].
    Delepine N; Desbois JC; Delepine G; Cornille H; Astier A; Alkallaf S
    Bull Cancer; 1989; 76(8):913-8. PubMed ID: 2620125
    [No Abstract]   [Full Text] [Related]  

  • 53. The correlation between dose of folinic acid and neurotoxicity in children and adolescents treated for osteosarcoma with high-dose methotrexate (HDMTX): a neuropsychological and psychosocial study.
    Bonda-Shkedi E; Arush MW; Kaplinsky C; Ash S; Goshen Y; Yaniv I; Cohen IJ
    J Pediatr Hematol Oncol; 2013 May; 35(4):271-5. PubMed ID: 23612378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute cardiac toxicity associated with high-dose intravenous methotrexate therapy: case report and review of the literature.
    Perez-Verdia A; Angulo F; Hardwicke FL; Nugent KM
    Pharmacotherapy; 2005 Sep; 25(9):1271-6. PubMed ID: 16164401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Neoadjuvant chemotherapy of osteosarcoma. Preliminary results of the cooperative COSS-86 osteosarcoma study].
    Bieling P; Bielack S; Delling G; Jürgens H; Kotz R; Dose C; Astheimer H; Exner G; Gadner H; Graf N
    Klin Padiatr; 1991; 203(4):220-30. PubMed ID: 1942929
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Osteosarcoma--is there a role for oral low-dose methotrexate.
    Harris MB
    Cancer Invest; 1989; 7(4):357-60. PubMed ID: 2686815
    [No Abstract]   [Full Text] [Related]  

  • 57. Monitoring methotrexate levels in osteosarcoma.
    Gorlick R; Meyers P; Kellick M; Bertino JR
    J Clin Oncol; 1998 Jun; 16(6):2290-1. PubMed ID: 9626240
    [No Abstract]   [Full Text] [Related]  

  • 58. Can primary osteosarcoma act as a third space after high-dose methotrexate?
    Bissett D; Kaye SB; Kerr DJ
    Eur J Cancer; 1991; 27(8):1060. PubMed ID: 1832895
    [No Abstract]   [Full Text] [Related]  

  • 59. Acetazolamide for alkalinisation of urine in patients receiving high-dose methotrexate.
    Shamash J; Earl H; Souhami R
    Cancer Chemother Pharmacol; 1991; 28(2):150-1. PubMed ID: 2060085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Indomethacin and protein binding of methotrexate.
    Raveendran R; Heybroek W; Caulfield M; Lawson M; Abrams SM; Wrigley PF; Slevin M; Turner P
    Hum Exp Toxicol; 1992 Jul; 11(4):291-3. PubMed ID: 1354980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.